<DOC>
	<DOCNO>NCT00983957</DOCNO>
	<brief_summary>The purpose study assess effect BMS-790052 pharmacokinetics Ortho Tri-Cyclen® healthy female subject .</brief_summary>
	<brief_title>Study Assess Effect BMS-790052 Pharmacokinetics Ortho Tri-Cyclen® Healthy Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>Key Healthy female subject , 1845 year , BMI 1832 kg/m² . Must use adequate method contraception avoid pregnancy throughout study . Key Abnormal Pap smear within 1 yr dosing , abnormal menstrual cycle 3 month prior enrollment . Any significant chronic uncontrolled medical illness .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>